Inappropriate ADH Syndrome
7 clinical trials · Condition
◉ Watch Inappropriate ADH Syndrome
| Record | Firm | Date |
|---|---|---|
| Urea for Chronic Hyponatremia (NCT04588207) | Helbert Rondon Berrios, MD, MS | 2021-12-28 |
| Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia (NCT01227512) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-10-01 |
| A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia (NCT00728091) | Sanofi | 2008-07-01 |
| Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (NCT00264914) | Sanofi | 2005-07-01 |
| Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (NCT00264927) | Sanofi | 2004-05-01 |
| "SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia (NCT00072683) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2003-04-01 |
Track Inappropriate ADH Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.